NOVAVAX 51.07 +5.50 +12.07%
Today Novavax is trading at 51.07 USD and the Shares of Novavax Inc. gained with 12.07% in the afternoon yesterday Monday after the biotechnology company said it is selling 4.4 million preferred shares to RA Capital Management for $200 million. The company announced that this 200 million dollar are going to fund the workings of the vaccine for the covid 19 which went into a Phase 1/2 clinical trial in May Novavax has also announced that the Department of Defense would manufacture the vaccine if it's successful in the clinic and would give Novavax up to $60 million as part of that contract in exchange for Novavax providing millions of doses of the experimental vaccine candidate to the DoD.